Mayo Clinic: Partnership to accelerate development of novel treatments for heart valve disease
Tuesday, November 18, 2014
9:30 AM - 9:55 AM
Every 60 seconds, a patient with aortic valve stenosis undergoes valve replacement surgery. Unfortunately, even when identified early, there are no treatments to slow progression of valve disease. Inspired by a National Institutes of Health (NIH)-sponsored drug repurposing grant, our team has rapidly evolved from discovery-based research laboratory to multidisciplinary team focused on developing novel treatments to slow progression of valve calcification and prevent the need for surgery. By partnering with academic drug development groups, pharmaceutical industry partners, medicinal chemists, NIH, Food and Drug Administration, and business development experts, we aim to accelerate the rate at which scientific discoveries move to clinical trials.
Jordan Miller, Assistant Professor, Departments of Surgery and Physiology, Mayo Clinic
View the presentation slides as a PDF